Department of Pathology, University of Louisville, Louisville, KY.
Department of Medicine, School of Medicine, University of Washington.
Am J Clin Oncol. 2022 Jan 1;45(1):28-35. doi: 10.1097/COC.0000000000000877.
Histologic grading using the Fédération Nationale des Centres de Lutte Contre Le Cancer (FNCLCC) system is not universally accepted as applicable to malignant peripheral nerve sheath tumor (MPNST), as its prognostic value is not well established.
We retrospectively evaluated 99 cases of MPNST to investigate any association between the outcomes overall survival (OS) and progression-free survival (PFS), and predictor variables FNCLCC grade, clinical setting, tumor location, and tumor size at diagnosis using multivariable Cox proportional hazard analysis.
Univariable and multivariable analysis demonstrate a statistically significant association between FNCLCC grade and both OS and PFS when comparing tumors by histologic grade. Of note, no deaths were observed in patients with grade 1 MPNST. Other variables associated with unfavorable outcomes include fragmented resection and primary site, with tumors in the extremities having favorable OS, but not PFS, when compared with those in truncal locations. Tumors in the head and neck had favorable PFS, but not OS, compared with those in the trunk. No statistically significant differences in OS or PFS were observed when comparing patient age and sex, tumor size at diagnosis, clinical setting (primary vs. type-1 neurofibromatosis vs. radiation associated) or history of neoadjuvant therapy. Interobserver agreement for FNCLCC grading of these tumors was considered good (S*=0.77, 95% confidence interval: 0.71-0.84).
Association between FNCLCC grading and survival outcomes in MPNST suggests potential value to routinely grading these neoplasms. However, the subjectivity of the grading system, particularly when assigning a tumor differentiation score, may pose a challenge, especially in low and intermediate grade lesions.
FNCLCC 系统的组织学分级并未被普遍认为适用于恶性外周神经鞘瘤(MPNST),因为其预后价值尚未得到充分证实。
我们回顾性评估了 99 例 MPNST 病例,通过多变量 Cox 比例风险分析,研究总生存期(OS)和无进展生存期(PFS)与预测变量 FNCLCC 分级、临床背景、肿瘤位置以及诊断时肿瘤大小之间的关系。
单变量和多变量分析表明,在按组织学分级比较肿瘤时,FNCLCC 分级与 OS 和 PFS 之间存在统计学显著关联。值得注意的是,1 级 MPNST 患者无一例死亡。其他与不良结局相关的变量包括肿瘤部分切除和原发部位,四肢肿瘤的 OS 有利,但 PFS 不利,与躯干部位相比。头颈部肿瘤的 PFS 有利,但 OS 不利,与躯干部位相比。比较患者年龄和性别、诊断时肿瘤大小、临床背景(原发性 vs. 1 型神经纤维瘤病 vs. 放射相关)或新辅助治疗史时,OS 或 PFS 无统计学差异。这些肿瘤的 FNCLCC 分级的观察者间一致性被认为是良好的(S*=0.77,95%置信区间:0.71-0.84)。
FNCLCC 分级与 MPNST 生存结局之间的关联表明,对这些肿瘤进行常规分级具有潜在价值。然而,分级系统的主观性,特别是在分配肿瘤分化评分时,可能会带来挑战,尤其是在低级别和中级别病变中。